FDA OKs expanded label for Lilly's TaltzSeeking AlphaThe FDA approves updated labeling for Eli Lilly's (NYSE:LLY) Taltz (ixekizumab) to include data on psoriasis in the genital area, the first time such data has been approved for inclusion for a medication for moderate-to-severe plaque psoriasis. Taltz ...